Fineotex Chemical conducted their conference call for Q1: FY 2022 today at 5:00 PM

Here are the conference call highlights.

Hit 'Retweet' to educate more investors ☎️🧵

Business Updates:

• Focusing to expand the portfolio in textile and homecare.
• Phase 1 of Ambarnath plant is expected to commission in Sept 2021.
• Appointed Arindam Choudhuri as new CEO. He has 2 decades of experience from the global textile chemical industry.
Partnership:

• Recently done JV with HealthGuard, for expanding in the Malaysia segment. This will provide scope in metal-free sustainable chemistry solutions that are anti-microbial and anti-viral.
• Tied up with Sasmira for R&D, where even Mr. Sanjay was alumini as welll.
Cleaning and Hygiene Business:

• Got FDA approval for disinfectant, and has also hired 10 sales team. There will addition of 16 more team members this quarter.
• This segment will be targeted to institutional segment targeting to corporate office, hospitals.
• With market opening up this segment is expected to grow well.
• Healthguard Guard is Billion $ opportunity and FCL is targeting 7-8% of market share. This is expected to generate revenue from the next quarter.
• HAIQ, DOW is the competitor for HealthGuard.
Industry:

• Unorganized market is currently struggling as recent norms of government is not feasible for small players.
• This has led to increase in the share of organized player.
• Foreign players are looking for China+1 which is benefiting India.
Raw Material:

• There was temporary shortage of raw material due to supply related issue. Post which there was sharp increase in Raw Material Price as well.
• These increased Raw Material price has also been passed on to customer.
Acquisition:

• Company is not looking for any big sort of acquisition, and mgmt would be disciplined in acquiring business.
• Acquisition won't be in new segment.
• Criteria of company would be looking at FCL, in terms of Margins, Debt and sales growth potential.
Sustainability:

• China + policy is leading to increasing customer for India and FCL as well.
• FCL has not looses any of its customers till now.
• Focus is not on big becoming bigger; but Fast becoming bigger. Hence strengthening the sales channel is the focus of the company
• Optimum utilization of business is around 75% and FCL currently stands at around 50-55% of utilization.

• Mgmt target Q4 of FY 2021 as the base scenario and expects to grow over that base unless there is risk covid.
For more discussion on Equity research and OI analysis

Subscribe to our YouTube channel 😃

Link 🖇: https://t.co/jnS3AV9kiv

You May Also Like

कुंडली में 12 भाव होते हैं। कैसे ज्योतिष द्वारा रोग के आंकलन करते समय कुंडली के विभिन्न भावों से गणना करते हैं आज इस पर चर्चा करेंगे।
कुण्डली को कालपुरुष की संज्ञा देकर इसमें शरीर के अंगों को स्थापित कर उनसे रोग, रोगेश, रोग को बढ़ाने घटाने वाले ग्रह


रोग की स्थिति में उत्प्रेरक का कार्य करने वाले ग्रह, आयुर्वेदिक/ऐलोपैथी/होमियोपैथी में से कौन कारगर होगा इसका आँकलन, रक्त विकार, रक्त और आपरेशन की स्थिति, कौन सा आंतरिक या बाहरी अंग प्रभावित होगा इत्यादि गणना करने में कुंडली का प्रयोग किया जाता है।


मेडिकल ज्योतिष में आज के समय में Dr. K. S. Charak का नाम निर्विवाद रूप से प्रथम स्थान रखता है। उनकी लिखी कई पुस्तकें आज इस क्षेत्र में नए ज्योतिषों का मार्गदर्शन कर रही हैं।
प्रथम भाव -
इस भाव से हम व्यक्ति की रोगप्रतिरोधक क्षमता, सिर, मष्तिस्क का विचार करते हैं।


द्वितीय भाव-
दाहिना नेत्र, मुख, वाणी, नाक, गर्दन व गले के ऊपरी भाग का विचार होता है।
तृतीय भाव-
अस्थि, गला,कान, हाथ, कंधे व छाती के आंतरिक अंगों का शुरुआती भाग इत्यादि।

चतुर्थ भाव- छाती व इसके आंतरिक अंग, जातक की मानसिक स्थिति/प्रकृति, स्तन आदि की गणना की जाती है


पंचम भाव-
जातक की बुद्धि व उसकी तीव्रता,पीठ, पसलियां,पेट, हृदय की स्थिति आंकलन में प्रयोग होता है।

षष्ठ भाव-
रोग भाव कहा जाता है। कुंडली मे इसके तत्कालिक भाव स्वामी, कालपुरुष कुंडली के स्वामी, दृष्टि संबंध, रोगेश की स्थिति, रोगेश के नक्षत्र औऱ रोगेश व भाव की डिग्री इत्यादि।